All Stories

  1. Neddylation inhibition impairs spine development, destabilizes synapses and deteriorates cognition
  2. Variability assessment of 15N metabolic labeling-based proteomics workflow in mouse plasma and brain
  3. Protein Profiling and Phosphoprotein Analysis by Isoelectric Focusing
  4. Blood Mononuclear Cell Proteome Suggests Integrin and Ras Signaling as Critical Pathways for Antidepressant Treatment Response
  5. Brain Quantitative Proteomics Combining GeLC-MS and Isotope-Coded Protein Labeling (ICPL)
  6. Psychiatric patient stratification using biosignatures based on cerebrospinal fluid protein expression clusters
  7. 15N metabolic labeling: Evidence for a stable isotope effect on plasma protein levels and peptide chromatographic retention times
  8. B-Raf and CRHR1 Internalization Mediate Biphasic ERK1/2 Activation by CRH in Hippocampal HT22 Cells
  9. Proteomic and metabolomic profiling reveals time-dependent changes in hippocampal metabolism upon paroxetine treatment and biomarker candidates
  10. Proteome profiling of peripheral mononuclear cells from human blood
  11. The15N isotope effect inEscherichia coli: A neutron can make the difference
  12. MALDI imaging mass spectrometry reveals COX7A2, TAGLN2 and S100-A10 as novel prognostic markers in Barrett's adenocarcinoma
  13. The 15N isotope effect as a means for correlating phenotypic alterations and affected pathways in a trait anxiety mouse model
  14. PROTEOME ANALYSES OF POST-MORTEM BRAIN TISSUE FROM PATIENTS WITH SCHIZOPHRENIA SUGGEST DYSFUNCTION OF OLIGODENDROCYTES AND ASTROCYTES AND POTENTIAL BIOMARKER CANDIDATES?
  15. Cerebrospinal Fluid Biomarkers for Major Depression Confirm Relevance of Associated Pathophysiology
  16. MALDI Imaging Identifies Prognostic Seven-Protein Signature of Novel Tissue Markers in Intestinal-Type Gastric Cancer
  17. Characterization of the B-Raf interactome in mouse hippocampal neuronal cells
  18. Erratum to Proteomic analysis of dorsolateral prefrontal cortex indicates the involvement of cytoskeleton, oligodendrocyte, energy metabolism and new potential markers in schizophrenia [Journal of Psychiatric Research (2009); 43(11): 978–86]
  19. Proteome analysis of the thalamus and cerebrospinal fluid reveals glycolysis dysfunction and potential biomarkers candidates for schizophrenia
  20. Profiling of mouse synaptosome proteome and phosphoproteome by IEF
  21. Methylglyoxal-mediated anxiolysis involves increased protein modification and elevated expression of glyoxalase 1 in the brain
  22. Shotgun Mass Spectrometry Workflow Combining IEF and LC-MALDI-TOF/TOF
  23. Proteome analysis of schizophrenia brain tissue
  24. Stable Isotope Metabolic Labeling with a Novel 15N-Enriched Bacteria Diet for Improved Proteomic Analyses of Mouse Models for Psychopathologies
  25. Regulation of proteins mediating neurodegeneration in experimental autoimmune encephalomyelitis and multiple sclerosis
  26. A MS data search method for improved 15 N-labeled protein identification
  27. Proteomic analysis of dorsolateral prefrontal cortex indicates the involvement of cytoskeleton, oligodendrocyte, energy metabolism and new potential markers in schizophrenia
  28. Shotgun mass spectrometry analysis of the human thalamus proteome
  29. Prefrontal cortex shotgun proteome analysis reveals altered calcium homeostasis and immune system imbalance in schizophrenia
  30. QuantiSpec — Quantitative mass spectrometry data analysis of 15N-metabolically labeled proteins
  31. Alterations in oligodendrocyte proteins, calcium homeostasis and new potential markers in schizophrenia anterior temporal lobe are revealed by shotgun proteome analysis
  32. Proteome analysis of human dorsolateral prefrontal cortex using shotgun mass spectrometry
  33. CRHR1-dependent effects on protein expression and posttranslational modification in AtT-20 cells
  34. Biomarker discovery in CSF of depressed patients
  35. Interrogation of MS/MS search data with anpI Filter algorithm to increase protein identification success
  36. Phosphopeptide enrichment by IEF
  37. The quest for brain disorder biomarkers*
  38. In-depth analysis of the human CSF proteome using protein prefractionation
  39. Mining the human cerebrospinal fluid proteome by immunodepletion and shotgun mass spectrometry
  40. Analysis of cerebrospinal fluid of depressed patients
  41. Characterization of cyanogen bromide fragments of reduced human serum albumin by matrix-assisted laser desorption/ionization mass spectrometry
  42. Isolation by gel-permeation chromatography of a non-covalent complex of Cibacron Blue F3G-A with human serum albumin
  43. Tryptic peptide mapping of sequence 299–585 of human serum albumin by high-performance liquid chromatography and fast atom bombardment mass spectrometry